NasdaqGS:JAZZPharmaceuticals
A Look At Jazz Pharmaceuticals (JAZZ) Valuation After A Strong Multi Period Share Price Run
Recent performance context
Jazz Pharmaceuticals (JAZZ) has drawn investor interest after solid recent returns, with the stock up roughly 18% over the past month and about 24% over the past 3 months based on provided data.
See our latest analysis for Jazz Pharmaceuticals.
That recent momentum sits on top of a 36.6% year to date share price return and a very large 118.8% 1 year total shareholder return, suggesting sentiment has strengthened over both shorter and longer horizons.
If this kind of...